Genecast Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

Genecast General Information

Description

Developer of cancer diagnostic technology equipment designed to detect, diagnose, and treat early-stage cancer. The company's technology amplifies only mutated genes while leaving the normal genes intact, and its liquid biopsy method analyzes mutant tumor DNA in the blood, enabling cancer patients to receive effective treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 10009 Garden 5 Techno Hall
  • 66, Chungmin-ro, Songpa-gu
  • Seoul, 05838
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • Number 10009 Garden 5 Techno Hall
  • 66, Chungmin-ro, Songpa-gu
  • Seoul, 05838
  • South Korea
+82

Genecast Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genecast Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Apr-2026 Completed Generating Revenue
5. Later Stage VC 05-Jun-2024 Completed Generating Revenue
4. Later Stage VC (Series C) 23-Feb-2023 Completed Generating Revenue
3. Early Stage VC (Series B) 08-Jun-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 01-May-2018 $4.85M $4.85M Completed Startup
1. Seed Round 01-Dec-2017 Completed Startup
To view Genecast’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genecast Patents

Genecast Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025105837-A1 Method for large-scale multiplex detection of lung cancer mutant genes using rna and kit for large-scale multiplex detection of lung cancer mutant genes using same Inactive 15-Nov-2023
WO-2020145734-A1 Dna polymerase for detecting braf mutations, and kit comprising same Inactive 11-Jan-2019
WO-2020145715-A1 Dna polymerase for detecting tert mutation and kit comprising same Inactive 11-Jan-2019
WO-2020145711-A1 Dna polymerase for egfr mutation detection and kit comprising same Inactive 11-Jan-2019
WO-2020145762-A1 Dna polymerase for jak2 mutation detection, and kit comprising same Inactive 11-Jan-2019 C12Q1/686
To view Genecast’s complete patent history, request access »

Genecast Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genecast Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Winvest Venture Capital Venture Capital Minority
Access Bio Corporation Minority
DK&D Corporation Minority
GC Biopharma Corporation Minority
GC Medis Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Genecast FAQs

  • When was Genecast founded?

    Genecast was founded in 2016.

  • Where is Genecast headquartered?

    Genecast is headquartered in Seoul, South Korea.

  • What is the size of Genecast?

    Genecast has 16 total employees.

  • What industry is Genecast in?

    Genecast’s primary industry is Diagnostic Equipment.

  • Is Genecast a private or public company?

    Genecast is a Private company.

  • What is Genecast’s current revenue?

    The current revenue for Genecast is .

  • How much funding has Genecast raised over time?

    Genecast has raised $23.5M.

  • Who are Genecast’s investors?

    Winvest Venture Capital, Access Bio, DK&D, GC Biopharma, and GC Medis are 5 of 9 investors who have invested in Genecast.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process